Development and Initial Implementation of a Clinical Monitoring Strategy in a Non-regulated Trial: a research note from the ReStOre II Trial [version 3; peer review: 2 approved, 1 approved with reservations]

Bibliographic Details
Title: Development and Initial Implementation of a Clinical Monitoring Strategy in a Non-regulated Trial: a research note from the ReStOre II Trial [version 3; peer review: 2 approved, 1 approved with reservations]
Authors: Linda O'Neill, Camille Poisson, Fiona Murphy, Juliette Hussey, Emer Guinan, Derval Reidy
Source: HRB Open Research, Vol 6 (2024)
Publisher Information: F1000 Research Ltd, 2024.
Publication Year: 2024
Collection: LCC:Medicine
Subject Terms: Monitoring, Non-regulated trial, Independent Data Monitoring Committee, eng, Medicine
More Details: Background Data and Safety Monitoring is integral to quality assurance of clinical trials. Although monitoring is a core legal component of regulated clinical trials, non-regulated trials are not mandated to incorporate monitoring. Consequently, the monitoring process has been underutilised and underreported in this setting. This research report outlines the development and plans for implementing a bespoke Clinical Monitoring Strategy within the ‘Rehabilitation Strategies Following Oesophagogastric and Hepatopancreaticobiliary Cancer (ReStOre II) Trial’, a non-regulated trial comparing a 12-week multidisciplinary programme of rehabilitation to standard care in a cohort of 120 cancer survivors. Methods This research note provides a detailed overview of the ReStOre II Clinical Monitoring Strategy and describes the development of the strategy pre and post awarding of the grant. The strategy consists of the establishment and implementation of a comprehensive trial governance structure, inclusive of a Trial Management Group, Trial Steering Committee Meeting, and Independent Data Monitoring Committee. In addition, external trial monitoring by the Clinical Research Facility at St James’s Hospital. Three monitoring visits will be conducted during the trial; i) site initiation visit, ii) interim monitoring visit, and iii) close our visit. Results The Clinical Monitoring Strategy has been finalised and is currently being implemented within the ReStOre II Trial. Two site initiation visits and one interim monitoring visit have been completed to date. Conclusion This research note provides a template for implementation of a Clinical Monitoring Strategy in a non-regulated clinical trial. Registration ReStOre II Trial: https://clinicaltrials.gov/ct2/show/NCT03958019
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2515-4826
Relation: https://hrbopenresearch.org/articles/6-46/v3; https://doaj.org/toc/2515-4826
DOI: 10.12688/hrbopenres.13763.3
Access URL: https://doaj.org/article/a7f58bd1bfd2484e92a931c97df3ea3c
Accession Number: edsdoj.7f58bd1bfd2484e92a931c97df3ea3c
Database: Directory of Open Access Journals
More Details
ISSN:25154826
DOI:10.12688/hrbopenres.13763.3
Published in:HRB Open Research
Language:English